(Q39869935)

15 September 2017

title

Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides (English)

1 reference

15 September 2017

author

Manuel-Elkin Patarroyo

5

object named as

Manuel E Patarroyo

1 reference

15 September 2017

Elena Mata

1

1 reference

15 September 2017

Manoli Igartua

2

1 reference

15 September 2017

Rosa M Hernández

3

1 reference

15 September 2017

Jaiver E Rosas

4

1 reference

15 September 2017

José L Pedraz

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

17

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

490-499

1 reference

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Naturally acquired antibodies to the glutamate-rich protein are associated with protection against plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Aluminium adjuvants--in retrospect and prospect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Progress and challenges for malaria vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Measurement of protein using bicinchoninic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

The global distribution of clinical episodes of Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Mouse strain-dependent differences in enhancement of immune responses by C3d.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Protein instability in poly(lactic-co-glycolic acid) microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Defined synthetic vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

Stability of BSA encapsulated into PLGA microspheres using PAGE and capillary electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2010.483254

10.3109/10717544.2010.483254

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference